Latest / The BioHub - by Avetix
Episode 103 - Justin To - CEO of QED Therapeutics, a Bridge Bio Company
Today’s guest is Justin To, a leader at the forefront of biotech innovation and gene therapy. Justin currently serves as CEO of QED Therapeutics, a BridgeBio company, where he helps guide the development of treatments for rare genetic diseases.
With a background that spans strategy consulting at McKinsey, healthcare technology at Flatiron Health, and multiple leadership roles at BridgeBio, Justin brings a unique blend of scientific rigor, operational leadership, and business insight. He’s worked across the full lifecycle of drug development—from early strategy to commercialization—always with…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.